Keratoconjunctivitis as a Single Entity in X-linked Agammaglobulinemia?

Ocul Immunol Inflamm. 2023 Apr;31(3):665-670. doi: 10.1080/09273948.2022.2042824. Epub 2022 Apr 11.

Abstract

Purpose: To report a case of a male patient with a severe corneal and conjunctival immunopathy likely caused by an X-linked agammaglobulinemia.

Methods: A clinical case report with observation results from 2001-2021.

Results: A severe corneal immunopathy of both eyes is reported in a retrospective long-term observation of nearly twenty years in a 32-year-old male patient with X-linked agammaglobulinemia (XLA). A chronic progressive corneal scarring with a loss of visual acuity and typical symptoms of a phlyctenular keratoconjunctivitis were observed.

Conclusion: Whereas steroid eye drops like dexamethasone could control the symptoms and the corneal scarring progression as short time therapy options, ciclosporin A eye drops showed problems in therapy adherence in long-time use. Antibiotic eye drops supported the anti-inflammatory therapy effects, but no typical pathogen was detected. Antineovascular subconjunctival application did not show any relevant effect in one-time use. Artificial tears were needed as basic therapy.

Keywords: Bruton syndrome; X-linked agammaglobulinemia; corneal immunopathy; corneal scarring; phlyctal keratoconjunctivitis.

Publication types

  • Case Reports

MeSH terms

  • Cicatrix*
  • Humans
  • Keratoconjunctivitis* / diagnosis
  • Keratoconjunctivitis* / drug therapy
  • Lubricant Eye Drops / therapeutic use
  • Male
  • Retrospective Studies

Substances

  • Lubricant Eye Drops

Supplementary concepts

  • Bruton type agammaglobulinemia